Abstract

BACKGROUND AND OBJECTIVES

Sickle cell trait and sickle cell disease are associated with faster GFR decline compared with normal hemoglobin phenotypes. We sought to compare the AKI risk in sickle cell trait/disease to normal hemoglobin phenotypes and investigate the association between AKI and GFR decline in sickle cell trait/disease.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS

This multicenter observational study used registry data (January 2005-June 2018) of adult Black patients with sickle cell trait/disease (exposures) and normal hemoglobin phenotype (reference) ascertained by hemoglobin electrophoresis. Outcomes of interest (incident AKI [1.5 times baseline serum creatinine or higher], incident severe AKI [doubling of baseline serum creatinine or higher], and incident sustained AKI [AKI persisting for ≥72 hours]) were adjudicated by chart review and evaluated by Cox regression. The association between AKI and GFR decline (linear mixed models) was also investigated.

RESULTS

We identified 8968 reference patients, 1279 patients with sickle cell trait, and 254 patients with sickle cell disease with a median follow-up of 7.6 years and mean baseline serum creatinine of 0.8 mg/dl. We observed 796 AKI events, 452 sustained AKI events, and 466 severe AKI events. Compared with people with a normal hemoglobin phenotype, sickle cell trait was associated with higher risk for sustained AKI (adjusted hazard ratio, 1.64; 95% confidence interval, 1.27 to 2.11), but not AKI (adjusted hazard ratio, 1.11; 95% confidence interval, 0.91 to 1.36) or severe AKI (adjusted hazard ratio, 1.26; 95% confidence interval, 0.96 to 1.64). Sickle cell disease was associated with AKI (adjusted hazard ratio, 2.85; 95% confidence interval, 2.13 to 3.81), severe AKI (adjusted hazard ratio, 2.38; 95% confidence interval, 1.65 to 3.42), and sustained AKI (adjusted hazard ratio, 2.50; 95% confidence interval, 1.68 to 3.71). Post-AKI GFR decline was significantly faster in sickle cell trait (0.37 ml/min per 1.73 m per year faster, <0.01) and disease (1.69 ml/min per 1.73 m per year faster, <0.01) compared with the reference.

CONCLUSIONS

Sickle cell trait and disease are associated with higher risk of AKI, which is associated with accelerated decline in eGFR.

MeSH

Incidence, Anemia, Sickle Cell, Risk, Kidney Diseases, Cells, Sickle Cell Trait, Nephrology, Confidence Intervals, Phenotype, Serum, Creatinine, Hemoglobins, Acute Kidney Injury

Cited by

• Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection. EJHaem, 2023
• Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis, 2022
• Postoperative complications in patients with sickle cell disease undergoing single-level anterior cervical discectomy and fusion. N Am Spine Soc J, 2025
• Inhibition of retinoic acid signaling in proximal tubular epithelial cells protects against acute kidney injury. JCI Insight, 2023
• Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice. Int J Mol Sci, 2025
• The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol, 2022
• A Scoping Review on Sex and Gender Differences in the Adverse Health Outcomes of Individuals with Sickle Cell Trait. Womens Health Rep (New Rochelle), 2025
• Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection. Blood Adv, 2021
• Determinants of Acute Kidney Injury in Children With Nephrotic Syndrome: A Prospective Observational Study. Cureus, 2025
• Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease. Am J Nephrol, 2024